Treatment strategy. Patients were stratified into 3 risk groups: R1, R2, and R3. The composition of therapy courses is given in Table 1. V, cytoreductive prophase; CR, complete response; SL-OP, second-look operation; ABMT, autologous BMT or blood stem cell transplantation.